Abivax (ABVX) Total Debt (2021 - 2026)
Abivax (ABVX) posted quarterly Total Debt of $1.3 million for Q1 2026, down 98.24% year-over-year from $73.4 million in Q1 2025, and down 57.48% quarter-over-quarter from $3.0 million in Q4 2025.
Abivax (ABVX) Total Debt (2021 - 2026) Analysis & Trends
Abivax's Total Debt history runs 6 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Total Debt fell 98.24% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 98.24% YoY), while the FY2025 annual figure was $3.0 million, down 97.51% from the prior year.
- Total Debt for Q1 2026 stood at $1.3 million, down from $3.0 million in the prior quarter.
- The five-year high for Total Debt was $121.8 million in Q4 2024, with the low at $1.3 million in Q1 2026.
- The 5-year median for Total Debt is $63.9 million (2025), against an average of $58.5 million.
- The sharpest annual moves came in 2025 and 2026: Total Debt surged 91.88% in 2025, then sank 98.24% in 2026.
- Abivax's Total Debt stood at $50.8 million in 2022, then soared by 63.17% to $82.9 million in 2023, then soared by 46.96% to $121.8 million in 2024, then plunged by 97.51% to $3.0 million in 2025, then tumbled by 57.48% to $1.3 million in 2026.
- Business Quant data shows ABVX's Total Debt at $1.3 million in Q1 2026, $3.0 million in Q4 2025, and $63.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 63.87 Mn |
| Jun 30, 2025 | 84.94 Mn |
| Mar 31, 2025 | 73.38 Mn |
| Dec 31, 2024 | 121.82 Mn |
| Jun 30, 2024 | 44.27 Mn |
| Dec 31, 2023 | 82.90 Mn |
| Dec 31, 2022 | 50.80 Mn |
| Dec 31, 2021 | 70.45 Mn |